Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 16 June 1989:
Vol. 244. no. 4910, pp. 1344 - 1346
DOI: 10.1126/science.2734614

Articles

Science, Vol 244, Issue 4910, 1344-1346
Copyright © 1989 by American Association for the Advancement of Science


articles

Implantation of vascular grafts lined with genetically modified endothelial cells

JM Wilson, LK Birinyi, RN Salomon, P Libby, AD Callow, and RC Mulligan

Whitehead Institute, Cambridge, MA.

The possibility of using the vascular endothelial cell as a target for gene replacement therapy was explored. Recombinant retroviruses were used to transduce the lacZ gene into endothelial cells harvested from mongrel dogs. Prosthetic vascular grafts seeded with the genetically modified cells were implanted as carotid interposition grafts into the dogs from which the original cells were harvested. Analysis of the graft 5 weeks after implantation revealed genetically modified endothelial cells lining the luminal surface of the graft. This technology could be used in the treatment of atherosclerosis disease and the design of new drug delivery systems.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Defining the potential for cell therapy for vascular disease using animal models.
R. Gulati and R. D. Simari (2009)
Dis. Model. Mech. 2, 130-137
   Abstract »    Full Text »    PDF »
Current status of catheter- and stent-based gene therapy.
F. Sharif, K. Daly, J. Crowley, and T. O'Brien (2004)
Cardiovasc Res 64, 208-216
   Abstract »    Full Text »    PDF »
Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease.
L. G. Melo, M. Gnecchi, A. S. Pachori, D. Kong, K. Wang, X. Liu, R. E. Pratt, and V. J. Dzau (2004)
Arterioscler Thromb Vasc Biol 24, 1761-1774
   Abstract »    Full Text »    PDF »
Gene- and cell-based therapies for cardiovascular diseases: current status and future directions.
L.G Melo, M Gnecchi, A.S Pachori, K Wang, and V.J Dzau (2004)
Eur. Heart J. Suppl. 6, E24-E35
   Abstract »    Full Text »
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis.
D. H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, A. B. Tietz, R. Kirchmair, M. Silver, C. Curry, et al. (2004)
Circulation 110, 36-45
   Abstract »    Full Text »    PDF »
Gene Therapy and Endovascular Treatment of Intracranial Aneurysms.
E. Ribourtout and J. Raymond (2004)
Stroke 35, 786-793
   Abstract »    Full Text »    PDF »
Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells.
D. P. Griese, S. Achatz, C. A. Batzlsperger, U. G. Strauch, B. Grumbeck, J. Weil, and G. A.J. Riegger (2003)
Cardiovasc Res 58, 469-477
   Abstract »    Full Text »    PDF »
Parathyroid Hormone and Parathyroid Hormone-related Protein Exert Both Pro- and Anti-apoptotic Effects in Mesenchymal Cells.
H.-L. Chen, B. Demiralp, A. Schneider, A. J. Koh, C. Silve, C.-Y. Wang, and L. K. McCauley (2002)
J. Biol. Chem. 277, 19374-19381
   Abstract »    Full Text »    PDF »
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries.
P. Golino, P. Cirillo, P. Calabro', M. Ragni, D. D'Andrea, E. V. Avvedimento, F. Vigorito, N. Corcione, F. Loffredo, and M. Chiariello (2001)
J. Am. Coll. Cardiol. 38, 569-576
   Abstract »    Full Text »    PDF »
Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon?.
D. W. Losordo and J. M. Isner (2001)
J. Am. Coll. Cardiol. 37, 2131-2135
   Full Text »    PDF »
Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics.
V. J. Dzau, M. J. Mann, A. Ehsan, and D. P. Griese (2001)
J. Thorac. Cardiovasc. Surg. 121, 0206-216
   Full Text »    PDF »
Impact of genomics on drug discovery and clinical medicine.
G. Emilien, M. Ponchon, C. Caldas, O. Isacson, and J.-M. Maloteaux (2000)
QJM 93, 391-423
   Abstract »    Full Text »    PDF »
Fibrinogen and Vascular Smooth Muscle Cell Grafts Promote Healing of Experimental Aneurysms Treated by Embolization • Editorial Comment.
J. Raymond, A. C. Desfaits, D. Roy, and J. P. Muizelaar (1999)
Stroke 30, 1657-1664
   Abstract »    Full Text »    PDF »
Endothelial Implants Inhibit Intimal Hyperplasia After Porcine Angioplasty.
H. M. Nugent, C. Rogers, and E. R. Edelman (1999)
Circ. Res. 84, 384-391
   Abstract »    Full Text »    PDF »
Molecular advances in cardiac and cardiovascular disease.
A. Basile-Borgia, J. H Abel, and H. Mahloogi (1999)
Perfusion 14, 89-99
   Abstract »    PDF »
Vascular Gene Transfer : From Bench to Bedside.
I. J. Kullo, R. D. Simari, and R. S. Schwartz (1999)
Arterioscler Thromb Vasc Biol 19, 196-207
   Full Text »    PDF »
Intimal Hyperplasia, Arterial Remodeling, and Restenosis: An Overview.
J. Heckenkamp and G. M. Lamuraglia (1999)
Perspectives in Vascular Surgery and Endovascular Therapy 11, 71-94
   Abstract »    PDF »
Is Gene Therapy for Hypertension Possible?.
M. I. Phillips (1999)
Hypertension 33, 8-13
   Full Text »    PDF »
A new approach to fighting cancer?.
T. N. Sato (1998)
PNAS 95, 5843-5844
   Full Text »    PDF »
Gene Therapy for Restenosis : Getting Nearer the Heart of the Matter.
S. Baek and K. L. March (1998)
Circ. Res. 82, 295-305
   Abstract »    Full Text »    PDF »
Gene Therapy of Restenosis : Promise and Perils.
P. Libby (1998)
Circ. Res. 82, 404-406
   Full Text »    PDF »
Optimal techniques for arterial gene transfer.
L. J Feldman and G. Steg (1997)
Cardiovasc Res 35, 391-404
   Abstract »    Full Text »    PDF »
Transfection of human endothelial cells.
F. C Tanner, D. P Carr, G. J Nabel, and E. G Nabel (1997)
Cardiovasc Res 35, 522-528
   Abstract »    Full Text »    PDF »
Stent Endothelialization: Time Course, Impact of Local Catheter Delivery, Feasibility of Recombinant Protein Administration, and Response to Cytokine Expedition.
E. Van Belle, F. O. Tio, T. Couffinhal, L. Maillard, J. Passeri, and J. M. Isner (1997)
Circulation 95, 438-448
   Abstract »    Full Text »
In Vivo Gene Transfer and Gene Modulation in Hypertension Research.
V. J. Dzau and M. Horiuchi (1996)
Hypertension 28, 1132-1137
   Abstract »    Full Text »
Seeding of Vascular Grafts With Genetically Modified Endothelial Cells : Secretion of Recombinant TPA Results in Decreased Seeded Cell Retention In Vitro and In Vivo.
P. F. Dunn, K. D. Newman, M. Jones, I. Yamada, V. Shayani, R. Virmani, and D. A. Dichek (1996)
Circulation 93, 1439-1446
   Abstract »    Full Text »
Enhanced In Vivo Antithrombotic Effects of Endothelial Cells Expressing Recombinant Plasminogen Activators Transduced With Retroviral Vectors.
D. A. Dichek, J. Anderson, A. B. Kelly, S. R. Hanson, and L. A. Harker (1996)
Circulation 93, 301-309
   Abstract »    Full Text »
CARDIAC GENE TRANSFER BY INTRACORONARY INFUSION OF ADENOVIRUS VECTOR--MEDIATED REPORTER GENE IN THE TRANSPLANTED MOUSE HEART.
J. Lee, H. Laks, D. C. Drinkwater, A. Blitz, L. Lam, Y. Shiraishi, P. Chang, T. A. Drake, and A. Ardehali (1996)
J. Thorac. Cardiovasc. Surg. 111, 246-252
   Abstract »    Full Text »
Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease.
R. T. Rowland, J. C. Cleveland Jr, X. Meng, A. H. Harken, and J. M. Brown (1995)
Ann. Thorac. Surg. 60, 721-728
   Abstract »    Full Text »
Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery.
T. Asahara, C. Bauters, C. Pastore, M. Kearney, S. Rossow, S. Bunting, N. Ferrara, J. F. Symes, and J. M. Isner (1995)
Circulation 91, 2793-2801
   Abstract »    Full Text »
Genetic Models of Human Vascular Disease.
V. J. Dzau, G. H. Gibbons, B. K. Kobilka, R. M. Lawn, and R. E. Pratt (1995)
Circulation 91, 521-531
   Abstract »    Full Text »
Gene Therapy for Cardiovascular Disease.
E. G. Nabel (1995)
Circulation 91, 541-548
   Full Text »
Vascular disease: the next target for local molecular therapeutics.
J McEwan, A Henney, and S Humphries (1994)
BMJ 308, 995-996
   Full Text »
Tissue engineering.
R Langer and J. Vacanti (1993)
Science 260, 920-926
   Abstract »    PDF »
The basic science of gene therapy.
R. Mulligan (1993)
Science 260, 926-932
   Abstract »    PDF »
Platelet-Endothelium Interactions.
J. A. Ware and D. D. Heistad (1993)
N. Engl. J. Med. 328, 628-635
   Full Text »
New methods of drug delivery.
R Langer (1990)
Science 249, 1527-1533
   Abstract »    PDF »
Site-specific gene expression in vivo by direct gene transfer into the arterial wall.
E. Nabel, G Plautz, and G. Nabel (1990)
Science 249, 1285-1288
   Abstract »    PDF »
Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer.
J. Wilson, A. Ping, J. Krauss, L Mayo-Bond, C. Rogers, D. Anderson, and R. Todd (1990)
Science 248, 1413-1416
   Abstract »    PDF »
Endothelial Cell Seeding: Is It Practical?.
A. D. Whittemore (1989)
Perspectives in Vascular Surgery and Endovascular Therapy 2, 126-132
   PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)